| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Cancer Research and Treatment Search > Browse Articles > Search



Reduced Dose Intensities of Doxorubicin in Elderly Patients with DLBCL in Rituximab Era
Hyerim Ha, Bhumsuk Keam, Tae Min Kim, Yoon Kyung Jeon, Se-Hoon Lee, Dong-Wan Kim, Chul Woo Kim, Dae Seog Heo
Cancer Res Treat. 2016;48(1):304-311.   Published online April 9, 2015    DOI: https://doi.org/10.4143/crt.2014.339
                           Web of Science 7  Crossref 8
A Case of Combined Hepatocellular-Cholangiocarcinoma with Favorable Response to Systemic Chemotherapy
Gun Min Kim, Hei-Cheul Jeung, Dokyung Kim, Joo Hoon Kim, Sang Hyun Yoon, Eun Suk Jung, Sang Joon Shin
Cancer Res Treat. 2010;42(4):235-238.   Published online December 31, 2010    DOI: https://doi.org/10.4143/crt.2010.42.4.235
                           Crossref 14
Combination Chemotherapy with Etoposide, Doxorubicin, Cisplatin (EAP) for Recurred or Metastatic Gastric
Nam Kuk Cho, Tae Sik Choi, Yeon Hee Park, Seung Chul Lee, Young Jin Yuh, Sung Rok Kim
J Korean Cancer Assoc. 2000;32(3):524-530.
      
Isolation of Differentially-Displayed cDNAs from a Doxrubicin Resistant Gastric Carcinoma Cell Line
Myung Soo Kang, Jae Ho Lee, Jae Gahb Park
J Korean Cancer Assoc. 1998;30(4):625-631.
      
Phase 2 study of Ifosfamide Single and Ifosfamide and Doxorubicin Combination Chemotherapy for Hepatocellular Carcinoma
Soo Jeong Park, Hyeoung Joon Kim, Chul Won Jung, Sang Jae Lee
J Korean Cancer Assoc. 1996;28(4):718-726.
      
Alterations in DNA Cleavage Site of Topoisomerase 2 by Benzo(a)pyrene , m-AMSA , Ellipticine and Doxorubicin in Human c-myc Protooncogene
Sang Wook Lee, In Cheol Jeong, Moo Youn Cho
J Korean Cancer Assoc. 1996;28(3):520-533.
      
A Phase 2 Study on Combined 5 - Fluorouracil , Etoposide , Doxorubicin and Cisplatin ( F - EAP ) in Patients with Advanced Gastric Cancer
J Korean Cancer Assoc. 1994;26(1):9-16.
      
Korean Cancer Association
E-Submission
EndNote Output Style
Email Alert
Journal Impact Factor 4.6
SCImago Journal & Country Rank
PubMed Central
MEDLINE/PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
Metadata
ORCID
COPE
Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Cancer Association.                 Developed in M2PI